Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis
- 17 July 2006
- journal article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 16 (4), 1545-1551
- https://doi.org/10.1111/j.1525-1438.2006.00625.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinomaMedical Molecular Morphology, 2004
- Malignant transformation of endometriosis and genetic alterations of K‐ras and microsatellite instabilityInternational Journal of Gynecology & Obstetrics, 2004
- Endometriosis and the neoplastic processReproduction, 2004
- Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2004
- p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancerGynecologic Oncology, 2003
- Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of EndometriosisThe American Journal of Pathology, 2002
- Role of Endometriosis in Cancer and Tumor DevelopmentAnnals of the New York Academy of Sciences, 2002
- Microsatellite DNA assays reveal an allelic imbalance in p16Ink4, GALT, p53, and APOA2 loci in patients with endometriosisFertility and Sterility, 2001
- Molecular Genetic Defects in EndometriosisGynecologic and Obstetric Investigation, 2000
- Heritability and molecular genetic studies of endometriosisHuman Reproduction Update, 2000